About Consonance Capital Partners

Consonance Capital Partners (“CCP”) is a private equity manager focused exclusively on the U.S. healthcare industry. CCP’s founders, Mitchell Blutt, MD, Benjamin Edmands, Stephen McKenna and Nancy-Ann DeParle partnered together for over a decade while at JPMorgan Partners and its successor and predecessor entities (collectively “JPMP”), and have over 65 years of combined experience in private equity investing, primarily within healthcare. CCP is currently investing out of a $500 million private equity fund. Having founded the healthcare practice group within JPMP in the 1980s, Mitchell Blutt, MD was an early pioneer in investing in healthcare private equity – leveraging his medical expertise to specialize exclusively on healthcare investing. With a history of successfully investing across multiple healthcare sub-sectors the principals bring a wealth of experience, insights, and an extensive network of relationships to existing and prospective management teams and portfolio companies.

 

The principals have successfully invested well over a billion dollars of equity capital in portfolio companies via growth equity, leveraged buyouts, and recapitalizations. Current and past private equity investments by the principals include Hand Innovations, K2M, DC Safety, Meta Pharmaceutical Services, Enclara Health, and KEPRO. In addition, select previous board seats held by the principals include, but are not limited to:

ASC Network

Owner and operator of ambulatory surgery centers

Cardinal Health

Wholesale pharmaceutical distributor

CareMore

Medicare Advantage plan

Cooper Holding

Outsourced diagnostic clinical services

DJO

Designer, manufacturer, and distributor of non-operative orthopedic products

General Medical

Distributor of medical and surgical supplies

Hanger Orthopedic Group

Orthotics and prosthetics provider

LHP Hospital Group

Owner and operator of acute care hospitals

Medical Arts Press

Marketer, cataloguer, manufacturer, and distributor of specialty office products and practice-related supplies

National Surgical Care

Surgery centers

TA Instruments

Manufacturer of analytical testing equipment and related disposables

Tenax

High precision plastic injection molder of medical products

Thermoscan

Infrared in-ear thermometers for professional and consumer use

Warner Chilcott, Inc

Specialty pharmaceutical manufacturer

 

CCP seeks to partner with world-class management teams in subsectors that have high growth opportunities. The founders take a collaborative approach to these relationships and believe that strong managers with aligned incentives are the backbone of a successful investment strategy. In addition, the principals have a robust history of working together with large corporations which are seeking to divest non-core assets and private/family-owned businesses which are seeking liquidity, growth capital, or both from knowledgeable, experienced, and partner-oriented healthcare investors.

 

Consonance Capital Partners benefits from its association with Consonance Capital Management, a healthcare-focused manager founded in 2005, whose activity is investing in public equities. The hedge fund leverages its private equity heritage to act as a unique and constructive public investor that catalyzes value creation in its portfolio companies.